President & CEO of Mirati Therapeutics Inc (30-Year Financial, Insider Trades) Charles M Baum (insider trades) sold 40,000 shares of MRTX on 04/17/2020 at an average price of $90.33 a share. The total sale was $3.6 million.
Mirati Therapeutics Inc is a biotechnology company. The company's focuses on precision medicine for oncology therapeutics. The company provides bioavailable inhibitors with distinct target profiles aiming to treat cancer patients. Mirati Therapeutics Inc has a market cap of $4.15 billion; its shares were traded at around $95.38 with and P/S ratio of 1059.78. Mirati Therapeutics Inc had annual average EBITDA growth of 9.30% over the past ten years. GuruFocus has detected 2 severe warning signs with Mirati Therapeutics Inc. .
CEO Recent Trades:
- President & CEO Charles M Baum sold 40,000 shares of MRTX stock on 04/17/2020 at the average price of $90.33. The price of the stock has increased by 5.59% since.
For the complete insider trading history of MRTX, click here
.- CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
- Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
- Double Buys: Companies that both Gurus and Insiders are buying
- Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.
